NCT02754544: Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

NCT02754544
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patient must be planning to undergo a tumor resection at the University of Texas M. D. Anderson Cancer Center for a newly diagnosed or recurrent metastatic brain tumor located in or adjacent to motor and/or speech brain areas
Exclusions: 
https://ClinicalTrials.gov/show/NCT02754544

Comments are closed.

Up ↑